Loading…
Live feed of every catalyst classified under Regulatory and Clinical.
Company reported a 92% Objective Response Rate in the study.
Company attempts another FDA nod after significant personnel change.
Company to share findings at an upcoming scientific conference.
Platform tested amid Congo outbreak with 246 cases.
Regulatory clearance expands company's product portfolio.
Company to progress potential clinical candidates for Hantavirus infection.
Topline results show 21% complete responses.
